0001185185-17-002221.txt : 20171031 0001185185-17-002221.hdr.sgml : 20171031 20171031142522 ACCESSION NUMBER: 0001185185-17-002221 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171030 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20171031 DATE AS OF CHANGE: 20171031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acacia Diversified Holdings, Inc. CENTRAL INDEX KEY: 0001001463 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MOTOR VEHICLES & MOTOR VEHICLE PARTS & SUPPLIES [5010] IRS NUMBER: 752095676 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14088 FILM NUMBER: 171165318 BUSINESS ADDRESS: STREET 1: 13575 58TH STREET NORTH - #138 CITY: CLEARWATER STATE: FL ZIP: 33760 BUSINESS PHONE: 727-678-4420 MAIL ADDRESS: STREET 1: 13575 58TH STREET NORTH - #138 CITY: CLEARWATER STATE: FL ZIP: 33760 FORMER COMPANY: FORMER CONFORMED NAME: ACACIA AUTOMOTIVE INC DATE OF NAME CHANGE: 20070209 FORMER COMPANY: FORMER CONFORMED NAME: GIBBS CONSTRUCTION INC DATE OF NAME CHANGE: 19950927 8-K 1 acaciadiversified8k103117.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
 
Pursuant to Section 13 OR 15(d) of the
 Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): October 30, 2017
 
Acacia Diversified Holdings, Inc.
(Exact Name of Registrant as Specified in Its Charter)
                           
Texas
1-14088
75-2095676
(State or Other Jurisdiction of Incorporation) 
 (Commission File Number) 
 (I.R.S. Employer Identification No.)
 
13575 58th Street North - #138 Clearwater, FL 33760
(Address of Principal Executive Offices)
 
(727) 678-4420
(Registrant’s Telephone Number, Including Area Code)
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Forward-Looking Statements
 
Statements in this current report on Form 8-K may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this current report. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.

Section 8 – Other Events
Item 8.01. Other Events.
On October 30, 2017, Acacia Diversified Holdings, Inc. (the “Company”), published the attached press release to announce that its wholly-owned subsidiary, Eufloria Medical of Tennessee, Inc. (“Eufloria”) has secured processing, manufacturing and retail sales licenses in Tennessee.  The acquisition of these licenses will allow Eufloria to conduct hemp-related business in Tennessee, as it moves forward in this new, emerging hemp marketplace.
Eufloria will focus on the growing, manufacturing and development of new and proprietary medicinal hemp products for people of Tennessee, using the Company’s USDA certified, organic, mobile CO2 processing and handling solutions for its retail customers in the expanding nutraceutical market.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit No.
 
Description
99
  
 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Acacia Diversified Holdings, Inc.
 
 
Date: October 30, 2017
/s/ Richard K. Pertile
 
Name: Richard K. Pertile
 
Title:  President/Chief Executive Officer

EX-99 2 ex99.htm EX-99

Exhibit 99
 
Acacia Diversified Holdings, Inc. Subsidiary Acquires Processing License in Tennessee
Clearwater, Florida
Acacia Diversified Holdings, Inc. (“Acacia” or the “Company”) (OTCQB symbol: ACCA), an emerging cannabis company, through its wholly owned subsidiary, Eufloria Medical of Tennessee, Inc. (“Eufloria”) is pleased to announce that Eufloria has secured a processing, manufacturing and retail sales license(s) in Tennessee.  The acquisition of these licenses will allow Eufloria to conduct hemp-related business in Tennessee, as it moves forward in this new emerging hemp marketplace.
Eufloria will focus on the growing, manufacturing and development of new and proprietary medicinal hemp products for people of Tennessee, using the Company’s USDA certified, organic, mobile CO2 processing and handling solutions for its retail customers in the expanding nutraceutical market.
“We are excited to announce our newest subsidiary, Eufloria Medical of Tennessee, Inc. and the acquisition of our seven-acre farm south of Nashville.  As a licensed, Tennessee grower, Eufloria intends to be fully operational by spring 2018 with retail operations opening as soon as November 2017.” said Richard K. Pertile, Acacia’s Chief Executive Officer, who has been overseeing the business of the Company since January 14, 2016.
For more information visit:  www.acaciadiversifiedholdings.com
www.marijinc.com
www.dahliasbotanicals.org

Forward-Looking Statements
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.